Nateglinide is a prescription oral hypoglycemic agent used to treat type 2 diabetes by stimulating insulin secretion from pancreatic beta cells. It belongs to the glinide class and is typically taken before meals to improve postprandial blood glucose control. The term combines a drug-name stem with the suffix -lide, reflecting its chemical family.
Full pronunciation guide